Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Microbiome analysis in the respiratory tract of individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis

PROVIDER: PRJNA1055940 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27326915_1.fastq.gz	Fastqsanger.gz
	SRR27326915_2.fastq.gz	Fastqsanger.gz
	SRR27326916_1.fastq.gz	Fastqsanger.gz
	SRR27326916_2.fastq.gz	Fastqsanger.gz
	SRR27326917_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 122

Similar Datasets

E-GEOD-39843

Project description:Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress

2025-01-24 | E-GEOD-39843 | ExpressionAtlas

Autologous transplantation of P63+ lung progenitor cells in patients with bronchiectasis: a randomized, single-blind, controlled trial

Project description:Non-cystic fibrosis bronchiectasis is a severe respiratory disease characterized by progressive loss of lung function, resulting in high morbidity and even early mortality. Current treatments cannot repair progressive lung damage, which encouraged the exploration of stem and progenitor cell-based regenerative therapies. In current study, we found that the P63+ progenitor cells normally located in airway basal layer could appear in the alveolar spaces of bronchiectasis patients. We successfully cloned and expanded the progenitor cells from the airway brushing tissues of patients. Then we conducted a randomized, single-blind, controlled, phase 1/2 trial to evaluate the safety and efficacy of autologous P63+ progenitor cells transplantation in bronchiectasis patients.

2024-10-15 | GSE261102 | GEO

human lung metagenome

Project description:Human respiratory viral metagenomes from cystic fibrosis and non-cystic fibrosis individuals

| PRJNA39545 | ENA

Metagenomic - human

Project description:The respiratory tract microbiome in children with Cystic Fibrosis

| PRJNA311065 | ENA

Pseudomonas aeruginosa

Project description:Pseudomonas aeruginosa lung infections in non-cystic fibrosis bronchiectasis

| PRJNA818324 | ENA

Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [CF_S1S3_5Auto_20CF_10HC]

Project description:The complex milieu of inflammatory mediators associated with many diseases is often too dilute to directly measure in the periphery, necessitating development of more sensitive measurements suitable for mechanistic studies, earlier diagnosis, guiding selection of therapy, and monitoring interventions. Previously, we determined that plasma of recent-onset (RO) Type 1 diabetes (T1D) patients induce a proinflammatory transcriptional signature in fresh peripheral blood mononuclear cells (PBMC) relative to that of unrelated healthy controls (HC). Here, using an optimized cryopreserved PBMC-based protocol, we compared the signature found between unrelated healthy controls and non-diabetic cystic fibrosis patients possessing Pseudomonas aeruginosa pulmonary tract infection. UPN727 cells were stimulated with autologous plasma (n=5), unrelated healthy control plasma (n=24), or plasma from patients with cystic fibrosis possessing Psuedomonas aeruginosa pulmonary tract infection (n=20). Gene expression analysis was perfromed in order to evaluate the transcriptional signature associated with cystic fibrosis.

2012-09-01 | E-GEOD-35711 | biostudies-arrayexpress

16S rRNA Amplicon Sequencing

Project description:A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome by 16S profiling

| PRJNA514329 | ENA

Project description:Respiratory mycobiome and microbiome in cystic fibrosis

| PRJNA433469 | ENA

Project description:Microbiome of different parts of the respiratory tract in children cystic fibrosis patients

| PRJNA591432 | ENA

Metaproteomic analysis of gut microbiota from 30 samples of cystic fibrosis infants

Project description:The link between human gut microbiota (a complex group of microorganisms including not only bacteria but also fungi, viruses, etc.,) and the physiological state is nowadays unquestionable. Metaproteomic has emerged as a useful technique to characterize this microbial community, not just taxonomically, but also focusing on specific biological processes carried out by gut microbiota that may have an effect in the host health or pathological state. Cystic fibrosis is a genetic disease in which the microbiota of the respiratory tract determines the patient's survival and differences in composition of gut microbiota of cystic fibrosis patients respect to healthy infants have been reported. In order to characterize this host-microbiota inter-relation, we carried out the metaproteomic study of 30 stool samples from infants with cystic fibrosis.

2022-10-11 | PXD029284 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data